Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenling Fuzheng prescription is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of immune reconstitution insufficiency in patients with HIV/AIDS. It is specifically indicated for patients exhibiting the TCM pattern of "Syndrome of qi deficiency and blood stasis." The prescription is designed to "Fuzheng" (strengthen the body's vital energy and resistance) to enhance immune recovery in HIV-infected individuals who fail to achieve adequate CD4+ T-cell counts despite effective antiretroviral therapy. The formula has been evaluated in clinical trials sponsored by The First Affiliated Hospital of Henan College of TCM as part of Chinese national scientific research initiatives for traditional medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenling Fuzheng prescription.